Pacemaker News and Research RSS Feed - Pacemaker News and Research

Study paves way for greater understanding of Attention Deficit Hyperactivity Disorder

Study paves way for greater understanding of Attention Deficit Hyperactivity Disorder

Researchers at the Angiocardioneurology Department of the Neuromed Scientific Institute for Research, Hospitalisation and Health Care of Pozzilli (Italy), have found, in animal models, that the absence of a certain enzyme causes a syndrome resembling the Attention Deficit Hyperactivity Disorder (ADHD). [More]
UW researchers use Activa PC+S DBS system to treat essential tremor

UW researchers use Activa PC+S DBS system to treat essential tremor

Essential tremor, a nervous system disorder that causes a rhythmic shaking in the hands, affects an estimated 10 million Americans and millions more worldwide. Deep brain stimulation, essentially a pacemaker for the brain, has been approved to treat essential tremor. But there is not an existing system that automatically provides electrical stimulation only when needed. [More]
EnteroMedics, American HealthCare Lending partner to support patient access to vBloc Therapy

EnteroMedics, American HealthCare Lending partner to support patient access to vBloc Therapy

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the Company has entered into a partnership with American HealthCare Lending to provide funding for patient access to vBloc Therapy, delivered via the Maestro Rechargeable System, for the treatment of obesity. [More]
CHLA develops first fully-implantable micropacemaker for use in fetus with complete heart block

CHLA develops first fully-implantable micropacemaker for use in fetus with complete heart block

A team of investigators at Children's Hospital Los Angeles and the University of Southern California have developed the first fully implantable micropacemaker designed for use in a fetus with complete heart block. The team has done preclinical testing and optimization as reported in a recent issue of the journal Heart Rhythm. [More]
Baroreflex activation therapy safe, effective for symptomatic advanced heart failure patients

Baroreflex activation therapy safe, effective for symptomatic advanced heart failure patients

Results of a clinical trial announced today at the American College of Cardiology Annual Scientific Session show a new type of therapy is safe and effective for symptomatic advanced heart failure patients who are already receiving optimum drug and device therapy. [More]
Patients who receive ablation during mitral valve surgery have less episodes of atrial fibrillation

Patients who receive ablation during mitral valve surgery have less episodes of atrial fibrillation

Patients with atrial fibrillation who received ablation while they were already undergoing surgery to correct a leaky heart valve had fewer episodes of atrial fibrillation a year later compared to patients who had the valve surgery alone, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session. [More]

83% of British people recognise that chronic pain is a serious medical condition, however only 15% receive proper treatment

Almost ten million people in the UK suffer from chronic pain, which has a major impact on quality of life and day to day activities, such as work; however many of those people do not have their pain under control or know how to go about seeking the right treatment. [More]

New protocol promises to transform remote monitoring of patients through implanted medical sensors

The ageing of society needs new, more cost-effective solutions to improve the life quality of patients and cut the burden that is placed on the social welfare system. [More]
Study provides new route for treating patients with difficult-to-treat Parkinson's symptoms

Study provides new route for treating patients with difficult-to-treat Parkinson's symptoms

Parkinson's disease patients treated with low-frequency deep brain stimulation show significant improvements in swallowing dysfunction and freezing of gait over typical high-frequency treatment. [More]

ETH Zurich researchers demonstrate promising method to fabricate cellulose-sheaths for implants

Artificial implants such as pacemakers often cause complications because the body identifies them as foreign objects. Researchers at ETH Zurich have now demonstrated a simple method to fabricate cellulose-sheaths for implants, whose micro-structured surface makes them especially biocompatible. [More]
Lung cancer in women: an interview with Harold Wimmer and Chuck Brynelsen

Lung cancer in women: an interview with Harold Wimmer and Chuck Brynelsen

We at the American Lung Association know that lung cancer is the number one cancer killer among women, however, there is a startling lack of information available to the public regarding lung cancer. [More]
St. Jude Medical receives CE Mark approval for Quadra Allure MP CRT-P

St. Jude Medical receives CE Mark approval for Quadra Allure MP CRT-P

St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval of the Quadra Allure MP™ cardiac resynchronization therapy pacemaker (CRT-P). [More]
Advances in fight against TB, sudden cardiac death

Advances in fight against TB, sudden cardiac death

Research projects into two of the biggest killers in worldwide health, tuberculosis and sudden cardiac death, will be the subjects of the University of Leicester Graduate School Doctoral Inaugural Lectures, delivered by two of the winners of this year's PhD prizes in the College of Medicine, Biological Sciences and Engineering. [More]
Preterm birth becomes world's number one killer of young children

Preterm birth becomes world's number one killer of young children

For the first time in history, the complications of preterm birth outrank all other causes as the world's number one killer of young children. [More]
University at Buffalo researchers receive $500,000 grant to study IED-induced vision loss

University at Buffalo researchers receive $500,000 grant to study IED-induced vision loss

It's well known that battlefield explosions can cause hearing loss, but veterans may be surprised to learn that their vision may also suffer — sometimes weeks or months after combat exposure. [More]
SCN clock isn't necessary to align body rhythms with light-dark cycle, study reveals

SCN clock isn't necessary to align body rhythms with light-dark cycle, study reveals

Circadian clocks regulate functions ranging from alertness and reaction time to body temperature and blood pressure. New research published in the November 2014 issue of The FASEB Journal further adds to our understanding of the circadian rhythm by suggesting that the suprachiasmaticus nucleus (SCN) clock, a tiny region of the hypothalamus considered to be the body's "master" timekeeper, is not necessary to align body rhythms with the light-dark cycle. [More]
BHVH cardiologists implant investigational cardiac pacemaker the size of multivitamin

BHVH cardiologists implant investigational cardiac pacemaker the size of multivitamin

Cardiologists on the medical staff at Baylor Jack and Jane Hamilton Heart and Vascular Hospital (BHVH) today implanted an investigational cardiac pacemaker the size of a multivitamin. [More]
Researchers discover rare disease that affects heart rate, intestinal movements

Researchers discover rare disease that affects heart rate, intestinal movements

Physicians and researchers at CHU Sainte-Justine, Universit- de Montr-al, CHU de Qu-bec, Universit- Laval, and Hubrecht Institute have discovered a rare disease affecting both heart rate and intestinal movements. [More]
EnteroMedics' CE Mark for Maestro System expanded to include management of Type 2 diabetes mellitus

EnteroMedics' CE Mark for Maestro System expanded to include management of Type 2 diabetes mellitus

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro Rechargeable (RC) System for obesity was expanded to include the management of Type 2 diabetes mellitus through improved glycemic control. [More]
St. Jude Medical gets CE Mark approval for updated labeling of Tendril STS, IsoFlex Optim pacing leads

St. Jude Medical gets CE Mark approval for updated labeling of Tendril STS, IsoFlex Optim pacing leads

St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval of updated labeling for its Tendril STS and IsoFlex Optim pacing leads, allowing existing and future patients with the devices access to magnetic resonance imaging (MRI) scans. [More]
Advertisement
Advertisement